PNC Financial Services Group
OKUR

PNC Financial Services Group’s OnKure Therapeutics OKUR Stock Holding History

PNC Financial Services Group’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-35
Closed -$533 – 4939
2024
Q2 		$533 Sell
35
-5
-13% -$85 ﹤0.01% 4521
2024
Q1 		$656 Buy
+40
New +$660 ﹤0.01% 4451

Other funds holding OKUR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PNC Financial Services Group's OKUR Position: Q3 2024 in Review

PNC Financial Services Group sold out of OnKure Therapeutics (OKUR) in Q3 2024, closing a stake of 35 shares — an estimated $533 sold.

PNC Financial Services Group first reported a position in OKUR in Q1 2024 and held it in 2 quarters. The position peaked at $656 in Q1 2024. 51 funds tracked by Wall St. Rank hold OKUR as of Q3 2024.

  • PNC Financial Services Group reported no remaining OnKure Therapeutics position as of Q3 2024 after selling out during the quarter.
  • PNC Financial Services Group sold 35 OnKure Therapeutics shares in Q3 2024, an estimated $533.
  • PNC Financial Services Group first reported a position in OnKure Therapeutics in Q1 2024 and held it in 2 quarters.
  • PNC Financial Services Group's OnKure Therapeutics position peaked at $656 in Q1 2024.
  • 51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q3 2024.

Based on PNC Financial Services Group's 13F filing for Q3 2024, filed 8 Nov 2024.